Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD)

J.P. Seale; R. Yoon; Philip Thompson; J.G. Armstrong; K. Murree-Allen; S.C. Morrison; P.A. Frith; P.W. Holmes; A.G. Veale; P.V. Zimmerman

Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD)

J.P. Seale, R. Yoon, Philip Thompson, J.G. Armstrong, K. Murree-Allen, S.C. Morrison, P.A. Frith, P.W. Holmes, A.G. Veale, P.V. Zimmerman

Research output: Chapter in Book/Conference paper › Conference paper

Original language	English
Title of host publication	Annual Scientific Meeting Thoracic Society of Australia and New Zealand
Place of Publication	Sydney
Publisher	Royal Australasian College of Physicians
Pages	446
Volume	24
Publication status	Published - 1994
Event	Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD) - Duration: 1 Jan 1994 → …

Conference

Conference	Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD)
Period	1/01/94 → …

Cite this

Seale, J. P., Yoon, R., Thompson, P., Armstrong, J. G., Murree-Allen, K., Morrison, S. C., Frith, P. A., Holmes, P. W., Veale, A. G., & Zimmerman, P. V. (1994). Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD). In Annual Scientific Meeting Thoracic Society of Australia and New Zealand (Vol. 24, pp. 446). Royal Australasian College of Physicians.

Seale, J.P. ; Yoon, R. ; Thompson, Philip ; Armstrong, J.G. ; Murree-Allen, K. ; Morrison, S.C. ; Frith, P.A. ; Holmes, P.W. ; Veale, A.G. ; Zimmerman, P.V. / Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD). Annual Scientific Meeting Thoracic Society of Australia and New Zealand. Vol. 24 Sydney : Royal Australasian College of Physicians, 1994. pp. 446

@inproceedings{73f1122788bd4699a416e89889869bcc,

title = "Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD)",

author = "J.P. Seale and R. Yoon and Philip Thompson and J.G. Armstrong and K. Murree-Allen and S.C. Morrison and P.A. Frith and P.W. Holmes and A.G. Veale and P.V. Zimmerman",

year = "1994",

language = "English",

volume = "24",

pages = "446",

booktitle = "Annual Scientific Meeting Thoracic Society of Australia and New Zealand",

publisher = "Royal Australasian College of Physicians",

note = "Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD) ; Conference date: 01-01-1994",

}

Seale, JP, Yoon, R, Thompson, P, Armstrong, JG, Murree-Allen, K, Morrison, SC, Frith, PA, Holmes, PW, Veale, AG & Zimmerman, PV 1994, Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD). in Annual Scientific Meeting Thoracic Society of Australia and New Zealand. vol. 24, Royal Australasian College of Physicians, Sydney, pp. 446, Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD), 1/01/94.

Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD). / Seale, J.P.; Yoon, R.; Thompson, Philip; Armstrong, J.G.; Murree-Allen, K.; Morrison, S.C.; Frith, P.A.; Holmes, P.W.; Veale, A.G.; Zimmerman, P.V.

Annual Scientific Meeting Thoracic Society of Australia and New Zealand. Vol. 24 Sydney : Royal Australasian College of Physicians, 1994. p. 446.

Research output: Chapter in Book/Conference paper › Conference paper

TY - GEN

T1 - Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD)

AU - Seale, J.P.

AU - Yoon, R.

AU - Thompson, Philip

AU - Armstrong, J.G.

AU - Murree-Allen, K.

AU - Morrison, S.C.

AU - Frith, P.A.

AU - Holmes, P.W.

AU - Veale, A.G.

AU - Zimmerman, P.V.

PY - 1994

Y1 - 1994

M3 - Conference paper

VL - 24

SP - 446

BT - Annual Scientific Meeting Thoracic Society of Australia and New Zealand

PB - Royal Australasian College of Physicians

CY - Sydney

T2 - Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD)

Y2 - 1 January 1994

ER -

Seale JP, Yoon R, Thompson P, Armstrong JG, Murree-Allen K, Morrison SC et al. Effects of ipratropium bromide (IP) and salbutamol (S), singly or in combination on airway function and quality of life (QOL) in chronic obstructive lung disease (COPD). In Annual Scientific Meeting Thoracic Society of Australia and New Zealand. Vol. 24. Sydney: Royal Australasian College of Physicians. 1994. p. 446